CAPP-seq

DEVICE2 trials

Sponsors

Stanford University, Jennifer Amengual

Conditions

LymphomaLymphoma, B-CellMalignant Lung NeoplasmMetastatic Malignant Neoplasm in the LungNon-Small Cell Lung CarcinomaStage IV Lung Cancer

Phase 1

CT Perfusion Imaging in Predicting Treatment Response in Patients With Non-small Cell Lung Cancer or Lung Metastases Treated With Stereotactic Ablative Radiation Therapy

CompletedNCT02693080

Stanford UniversityMalignant Lung Neoplasm, Metastatic Malignant Neoplasm in the Lung, Non-Small Cell Lung Carcinoma +1

Start: 2016-01-19End: 2020-04-29Updated: 2023-11-22

Phase 2

Defining ctDNA Metrics in Posttransplant Lymphoproliferative Disorder (PTLD)

RecruitingNCT06954805

Jennifer AmengualLymphoma, Lymphoma, B-Cell

Start: 2025-04-14End: 2028-04-14Target: 30Updated: 2026-05-27